Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Empower Clinics Inc EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.


GREY:EPWCF - Post by User

Comment by inviolablspiriton Aug 26, 2021 2:00pm
313 Views
Post# 33770348

RE:no brainer here

RE:no brainer hereGreat interview!  Lots of good information to digest. This will certainly be a great long term investment. However, I know many shareholders don't want to hear this, but at the current share price the company is fairly valued.  If the stock remains at a $10 million run rate for the year and giving it a 10x valuation that would place the stock at $0.30 and a $15 million run rate 10x, which could be more likely with clinic openings and testing would place the stock at $0.45.  If we happen to reach $20 million at 10x than we're looking at $0.60.  Those, objectively, are the numbers, whether you like them or not.  

I realize that the health industry can be valued greater than 10x, but that is a good place to start.  So I can see the company trading in the $0.30's and $0.40s for a bit until the revenues and quarterly financials start to show a higher valuation.  And this was generally what Steve is trying to say to shareholders is that we're not there yet, patience is needed, but we are in the process of building the company into something special.  And it will eventually get uplisted onto the NASDAQ and maybe even one day pay a dividend.  And George is right, that idea of a dividend is at least 5 years away or more.    

I've been an investor in this company since the $0.04 range and even I'll admit the share price had no business jumping all the way to $2.50.  In a way, it was harmful to the company because it created a lot of unhappy shareholders holding stock at higher prices, instead of bringing them in at lower prices for a slower and more solid ascent.  So I suspect we'll see some pressure from tax losses at some point before the end of the year.  But in the end, this is a great company, with a great future.  
<< Previous
Bullboard Posts
Next >>